PDCD1 and non-small cell lung carcinoma: Circ-FGFR1 enhances the expression of the motif chemokine receptor 4 (CXCR4) via miR-381-3p, thus promoting NSCLC progression and resistance to anti-programmed cell death 1 (PD-1)-based therapy (204).